Nidhish Tiwari is a Cardiology physician. OpenAlex indexes 58 publications with 275 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
234 E 149th St
Bronx, NY 104515589
Telephone
646-408-7740Provider last certified this registry record 13 Oct 2025.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20251 payment
- PFIZER INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
83.6%Statin21.5%Atorvastatin Calcium77%Rosuvastatin Calcium15%Pravastatin Sodium8%Part D<11 patientsBeta blocker20.1%Metoprolol Succinate49%Metoprolol Tartrate28%Carvedilol23%Part D≥63 patients+ 11 more classes in this area
Blood & clotting
9.8%Factor Xa inhibitor5.4%Eliquis70%Xarelto30%Part D<11 patientsVitamin K antagonist2.4%Warfarin Sodium100%Part D≥11 patients+ 1 more class in this area
Metabolism & gastrointestinal
6.6%SGLT2 inhibitor5.3%Jardiance72%Farxiga28%Part D<11 patientsPotassium supplement1.3%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 26-CCC-20992-ACC BRADYARRHYTHMIA IN ACUTE INTERMITTENT PORPHYRIA DUE TO DYSAUTONOMIA
Journal of the American College of Cardiology
2026 - DIAGNOSTIC ACCURACY OF CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY IN PRE-RENAL AND PRE-HEPATIC TRANSPLANT EVALUATION — A META-ANALYSIS
Journal of the American College of Cardiology
2025 - SAFETY AND EFFICACY OF PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE IMPLANTATION
Journal of the American College of Cardiology
2025 - Urgently expanding access to improved treatment for children with multidrug-resistant tuberculosis
The Lancet Child & Adolescent Health
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”